[1]
Caldarola, G. et al. 2024. Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian Cohort. Dermatology Practical & Conceptual. 14, 2 (Apr. 2024), e2024152. DOI:https://doi.org/10.5826/dpc.1402a152.